Sign In
Buy DHR
$178.08
+1.97 (+1.12%)
At Close: Jun 03, 2026
A Billionaire's Bet: 3 Stocks Dan Loeb Thinks You Should Own
12:44pm, Thursday, 10'th Aug 2023
It's not often that you read about activist investor Dan Loeb praising the chief executive officer (CEO) of a company in which Third Point Management holds a stake, but that's precisely what happened
Buy Alert: 3 Healthcare Stocks Nearing Super Attractive Entry Points
11:31am, Wednesday, 02'nd Aug 2023
As a prolific cog in the economic machine, the healthcare industry has been a roller coaster ride over the past few years. With the global pandemic, economic slowdown and industry-wide disruptions in
Time To Go Defensive With These ETFs
04:05am, Wednesday, 02'nd Aug 2023
High-beta stocks have outperformed defensive stocks in the stock market recently, raising questions about the effectiveness of low-volatility and dividend growth investing. ROBECO's research shows tha
7 Millionaire-Maker Healthcare Stocks to Buy Before the Window Closes
09:42am, Thursday, 27'th Jul 2023
Healthcare continues to be a major industry and economic driver around the world. According to the American Medical Association, spending on healthcare in the U.S. totals more than $4 trillion each ye
Is Danaher (DHR) Modestly Undervalued? An In-depth Analysis
02:32pm, Wednesday, 26'th Jul 2023
With a daily gain of 3.15% and Earnings Per Share (EPS) (EPS) of $8.52, Danaher Corp ( DHR , Financial) presents a compelling case for value investors. The question we aim to answer is: Is Danaher (DH
7 Growth Stocks You Better Be Buying on Each and Every Dip
03:42pm, Tuesday, 25'th Jul 2023
After a dismal 2022, investors have returned to the top growth stocks to buy with great enthusiasm. We shouldn't forget the lessons from 2022, however.
Danaher (DHR) Q2 Earnings Beat, Sales Decline 7.7% Y/Y
01:08pm, Tuesday, 25'th Jul 2023
Danaher's (DHR) Q2 earnings and revenues beat estimates. However, a decline in the sale of COVID-related products weigh on the top line.
Cramer's Mad Dash on Danaher: This is a true reset
11:21am, Tuesday, 25'th Jul 2023
CNBC's Jim Cramer delivers his daily Mad Dash.
Danaher (DHR) Q2 Earnings and Revenues Beat Estimates
08:37am, Tuesday, 25'th Jul 2023
Danaher (DHR) came out with quarterly earnings of $2.05 per share, beating the Zacks Consensus Estimate of $2 per share. This compares to earnings of $2.76 per share a year ago.
Danaher cuts forecast for annual sales growth as biotech clients face funding crunch
08:06am, Tuesday, 25'th Jul 2023
Danaher Corp on Tuesday cut its annual sales growth forecast for a second straight quarter, signaling that funding crunch in the drug development market was weighing on its biotechnology business.
Danaher: A Compounding Icon At A Fair Price
03:48am, Tuesday, 25'th Jul 2023
Danaher is an industry-leading serial acquirer with an iconic business system. After a boom in Danaher's sales during the pandemic, demand is now slowing as customers are facing inventory build-up and
Will Low COVID-Testing Volumes Mar Danaher's (DHR) Q2 Earnings?
03:03pm, Monday, 17'th Jul 2023
Lower demand for COVID-19 testing, vaccine and therapeutics is expected to have hurt Danaher's (DHR) Q2 performance. Rising cost of sales might have hurt the bottom line.
The 7 Most Undervalued Blue-Chip Stocks to Buy Now: June 2023
08:40pm, Tuesday, 27'th Jun 2023
Looking for undervalued blue-chip stocks to buy? This is a great time to be doing so.
Danaher (DHR) Shares Decline 10% YTD: What's Pulling It Down?
12:46pm, Monday, 26'th Jun 2023
Lower demand for COVID-19 testing, vaccine and therapeutics within the Biotechnology and Diagnostics segments weigh on Danaher (DHR).
Bear Of The Day: Danaher (DHR)
11:16am, Monday, 26'th Jun 2023
Despite a great history of beating the number, this stock is a Zacks Rank #5 (Strong Sell) as earnings estimates have fallen.
